Full-Time

Vice President

Posted on 1/12/2023

Editas Medicine

Editas Medicine

201-500 employees

Clinical stage genome editing for disease treatment

Biotechnology

Expert

Cambridge, MA, USA

Requirements
  • Previous experience in collection and handling metrics related to PV operations
  • Strong relationship building skills, with ability to interact effectively in a multifunctional and multicultural team setting
  • Excellent written and verbal communication skills to a variety of levels and teams, internally and externally
  • Demonstrated persuasion, influencing and negotiation skills
  • Ability to operate objectively and independently as a leader and as a member of matrix teams, as required
  • Effective team player, with proven ability to effectively lead projects and teams to successful conclusion
  • Hands on and motivated leader to drive the risk management and the clinical programs
  • Demonstrated ability to influence across a matrix structure, and to collaborate in a cross-functional environment
  • Highly organized and proficient in working in matrix team to support business and clinical program needs
  • Provides motivational leadership to the organization and improve its performance
  • Strong problem-solver and business acumen
  • Strong interpersonal, verbal and written communication skills organizational and workload planning skills along with the ability to manage multiple different projects simultaneously
  • Demonstrated ability as a line function manager
  • Exposure to and management of significant accelerations and challenges in clinical programs
  • MD or MD PHD with 15 years or more in industry with majority in Pharmacovigilance with prior experience of leading Pharmacovigilance for multiple clinical development programs
  • Experience or high comfort level in supporting clinical programs across multiple therapeutic areas, and bridging late to early development, familiarity with gene and/or cell therapy a plus
  • Ability to work with the Senior Executive Team and other external audiences such KOLs, regulatory bodies
  • Solid knowledge of relevant FDA, EU, ICH guidelines, initiatives and regulations governing both safety reporting and processing for clinical trial environments
  • Strong knowledge of MedDRA and common safety database
  • Demonstrated leadership and technical capabilities with the ability to simultaneously manage multiple different projects
Responsibilities
  • Be the leader of pharmacovigilance for Editas' clinical programs in partnership with Clinical Development, Biometrics, Clinical Operations and Regulatory Functions
  • Lead the safety and risk management of the clinical studies; monitor and analyze the safety data
  • Lead the development of risk management plans and associated documents to ensure that study-specific and health authority reporting requirements are met and that workflow between contract research organizations (CROs) and Editas is delineated
  • Ensures timely submission of expedited safety reports to Regulatory Authorities in conjunction with Regulatory Affairs and/or Contract Service Provider
  • Oversee and manage PV vendor(s) to ensure regulatory compliance and contractual obligations are met
  • Reviews the safety sections of clinical documents, including protocols, annual reports, investigational brochures, and other documents
  • Oversees SAE database reconciliation in collaboration with Data Management
  • Ensures compliance with global regulations and ICH guidelines to meet all drug safety and pharmacovigilance reporting requirements
  • Oversee preparation, development, implementation and maintenance of company SOPS and policies relating to pharmacovigilance and risk management to ensure compliance with ICH guidelines and applicable regulatory requirements
  • Knowledge of current US and international regulatory requirements; Maintain current with applicable PV global regulations, and industry guidelines. Responsible for all processes and operating procedures to ensure compliance with appropriate regulations and quality standards
  • Serve as the Pharmacovigilance subject matter expert for internal audits and FDA and global regulatory inspections and remediate any pharmacovigilance deficiencies found during regulatory or internal audits. Identify and follow-up on corrective action plans arising from audits and inspections
  • Implements PV quality management system including the identification and authoring of required procedural documents
  • Collect, analyze metric reports related to ICSRs, aggregate reports to ensure the systems and processes are compliant with the study specific plans, SOP and PV regulations
  • Author, review and approve SOPs as required
  • Escalate critical and major PV gaps to the management to ensure appropriate action
  • Support and participate in PV training of employees as needed
  • Demonstrated experience in communicating across several cross functional groups managing business process outsourcing vendors and relationships

Editas Medicine stands out as a leader in the field of genomic medicine, leveraging the potential of CRISPR gene editing technology to develop treatments for serious diseases. The company fosters a vibrant culture, encouraging collaboration and resilience among its team of 'Editors', and is committed to manufacturing and commercializing durable, precision genomic medicines. With a robust pipeline of treatments in development, Editas Medicine is not only repairing broken genes but also shaping the future of medicine.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

11%

1 year growth

25%

2 year growth

11%
INACTIVE